5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.62▲ | 2.61▲ | 2.61▲ | 2.66▼ | 2.69▼ |
MA10 | 2.62▲ | 2.61▲ | 2.62▲ | 2.68▼ | 2.75▼ |
MA20 | 2.62▲ | 2.63▲ | 2.65▼ | 2.71▼ | 2.90▼ |
MA50 | 2.65▼ | 2.68▼ | 2.71▼ | 2.77▼ | 3.19▼ |
MA100 | 2.72▼ | 2.72▼ | 2.67▼ | 2.94▼ | 2.46▲ |
MA200 | 2.69▼ | 2.72▼ | 2.79▼ | 3.14▼ | 7.03▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.003▲ | 0.000▲ | -0.007▼ | -0.017▼ |
RSI | 50.230▲ | 48.673▼ | 46.893▼ | 45.574▼ | 43.372▼ |
STOCH | 56.685 | 40.873 | 31.071 | 18.369▼ | 45.696 |
WILL %R | -28.571 | -28.571 | -50.000 | -84.127▼ | -64.216 |
CCI | 110.279▲ | 91.612 | 15.067 | -108.837▼ | -77.495 |
CDL | $KPRX Engulfing Candlestick Pattern Detected | Set Alert |
Thursday, September 04, 2025 04:59 PM
Detailed price information for Kiora Pharmaceuticals Inc. (KPRX-Q) from The Globe and Mail including charting and trades.
|
Thursday, September 04, 2025 04:14 AM
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its Chief Financial Officer, Melissa Tosca, CPA, will showcase the Company's ...
|
Friday, August 08, 2025 04:44 AM
Kiora Pharmaceuticals develops medicines for eye diseases that can cause blindness, particularly retinal degenerative diseases where few treatment options exist. Its lead product candidate, KIO-301, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 2.585 | 2.655 | 2.585 | 2.635 | 16,337 |
15/09/25 | 2.62 | 2.70 | 2.60 | 2.61 | 11,000 |
12/09/25 | 2.683 | 2.74 | 2.60 | 2.64 | 23,700 |
11/09/25 | 2.665 | 2.80 | 2.64 | 2.70 | 21,600 |
10/09/25 | 2.68 | 2.71 | 2.601 | 2.71 | 20,200 |
09/09/25 | 2.70 | 2.725 | 2.62 | 2.63 | 25,800 |
08/09/25 | 2.69 | 2.74 | 2.65 | 2.687 | 13,000 |
05/09/25 | 2.72 | 2.76 | 2.67 | 2.68 | 19,500 |
04/09/25 | 2.77 | 2.83 | 2.71 | 2.73 | 12,521 |
03/09/25 | 2.73 | 2.90 | 2.7201 | 2.80 | 81,161 |
|
|
||||
|
|
||||
|
|